Table 1.
Number of people with comorbidities, average pharmaceutical expenditure 2012
| Variable | Number | Percent |
|---|---|---|
| Male | 181,658 | 51.9 % |
| Female | 168,357 | 48.1 % |
| Total | 350,015 | 100 % |
| T2D Comorbidities related | ||
| Hypertension | 239,611 | 68.46 % |
| Dyslipidemia | 186,574 | 53.30 % |
| Severe obesity | 27,270 | 7.79 % |
| T2D Comorbidities Unrelated | ||
| Mental disorders | 87,673 | 25.05 % |
| Osteoarticular disease | 85,920 | 24.55 % |
| Thyroid disorders | 27,702 | 7.91 % |
| Osteoporosis | 25,861 | 7.39 % |
| COPD | 25,561 | 7.30 % |
| Cancer | 22,792 | 6.51 % |
| Alzheimer | 14,300 | 4.09 % |
| Asthma | 11,120 | 3.18 % |
| Pulmonary embolism | 964 | 0.28 % |
| Complications | ||
| Cardiovascular and cerebral disease | 50,567 | 14.45 % |
| Renal failure | 22,496 | 6.43 % |
| Retinopathy | 25,594 | 7.31 % |
| Neuropathy | 10,984 | 3.14 % |